John K Forrest

• Alexandra Lansky
• Carlos Mena-Hurtado
• Daniela Tirziu
• David J. Hur, MD, FACC, FASE, FSCCT, FSCMR
• Edward J Miller
• Eric Velazquez
• Harlan Krumholz
• James V. Freeman
• Jeptha Curtis
• Joseph Akar
• Kim Germaine Emiel Smolderen
• Robert McNamara
• Robert R Attaran
• Rohan Khera
• Roland Assi
• Thiruvengadam Muniraj

Cardiology; Heart Diseases; Stents; Transcatheter Aortic Valve Replacement

• 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsForrest JK, Deeb GM, Yakubov SJ, Rovin JD, Mumtaz M, Gada H, O'Hair D, Bajwa T, Sorajja P, Heiser JC, Merhi W, Mangi A, Spriggs DJ, Kleiman NS, Chetcuti SJ, Teirstein PS, Zorn GL, Tadros P, Tchétché D, Resar JR, Walton A, Gleason TG, Ramlawi B, Iskander A, Caputo R, Oh JK, Huang J, Reardon MJ. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients. Journal Of The American College Of Cardiology 2022, 79: 882-896. PMID: 35241222, DOI: 10.1016/j.jacc.2021.11.062.
• Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve StenosisForrest JK, Ramlawi B, Deeb GM, Zahr F, Song HK, Kleiman NS, Chetcuti SJ, Michelena HI, Mangi AA, Skiles JA, Huang J, Popma JJ, Reardon MJ. Transcatheter Aortic Valve Replacement in Low-risk Patients With Bicuspid Aortic Valve Stenosis. JAMA Cardiology 2020, 6: 50-57. PMID: 33031491, PMCID: PMC7542521, DOI: 10.1001/jamacardio.2020.4738.
• Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT RegistryForrest JK, Kaple RK, Ramlawi B, Gleason TG, Meduri CU, Yakubov SJ, Jilaihawi H, Liu F, Reardon MJ. Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT Registry. JACC Cardiovascular Interventions 2020, 13: 1749-1759. PMID: 32473890, DOI: 10.1016/j.jcin.2020.03.022.
• Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial WrapForrest JK, Mangi AA, Popma JJ, Khabbaz K, Reardon MJ, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Saul S, Qiao H, Oh JK, Williams MR. Early Outcomes With the Evolut PRO Repositionable Self-Expanding Transcatheter Aortic Valve With Pericardial Wrap. JACC Cardiovascular Interventions 2018, 11: 160-168. PMID: 29348010, DOI: 10.1016/j.jcin.2017.10.014.
• INITIAL USE OF THE EVOLUT PRO SELF-EXPANDING TRANSCATHETER AORTIC VALVEForrest J, Mangi A, Popma J, Khabbaz K, Reardon M, Kleiman N, Yakubov S, Watson D, Kodali S, George I, Tadros P, Zorn G, Brown J, Kipperman R, Staniloae C, Williams M. INITIAL USE OF THE EVOLUT PRO SELF-EXPANDING TRANSCATHETER AORTIC VALVE. Journal Of The American College Of Cardiology 2017, 69: 1288. DOI: 10.1016/s0735-1097(17)34677-6.
• Propensity-Matched Outcomes Comparing TAVR in Bicuspid vs Surgery in Tricuspid Aortic Valve StenosisDeeb G, Yakubov S, Reardon M, Ramlawi B, Chetcuti S, Kleiman N, Zahr F, Song H, Gada H, Mumtaz M, Ito S, Huang J, Forrest J. Propensity-Matched Outcomes Comparing TAVR in Bicuspid vs Surgery in Tricuspid Aortic Valve Stenosis. Journal Of The Society For Cardiovascular Angiography & Interventions 2023, 2: 100525. DOI: 10.1016/j.jscai.2022.100525.
• 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisForrest J, Deeb G, Yakubov S, Gada H, Mumtaz M, Ramlawi B, Bajwa T, Teirstein P, DeFrain M, Muppala M, Rutkin B, Chawla A, Jenson B, Chetcuti S, Stoler R, Poulin M, Khabbaz K, Levack M, Goel K, Tchétché D, Lam K, Tonino P, Ito S, Oh J, Huang J, Popma J, Kleiman N, Reardon M, Investigators L, Sorajja P, Byrne T, Kirshner M, Bajwa T, Crouch J, Coselli J, Silva G, Hebeler R, Stoler R, Islam A, Rousou A, Poulin M, Khabbaz K, Bladergroen M, Fail P, Netherland D, Lam K, Tonino W, Sudre A, Berthoumieu P, Tchétché D, Khalili H, Hughes G, Harrison J, De A, Tsau P, van Mieghem N, Larbalestier R, Yong G, Agarwal S, Martin W, Park S, Kleiman N, Reardon M, Mohammadi S, Rodes-Cabau J, Sparling J, Elkins C, Ganzel B, Matthews R, Starnes V, Ando K, Chevalier B, Farge A, DeFrain M, Muppala M, Combs W, Bagur R, Chu M, Fontana G, Dev V, Leya F, Tuchek J, Inglessis I, Jassar A, Piazza N, Lacappelle K, Steinberg D, Katz M, Wang J, Kozina J, Slachman F, Merritt R, Chawla A, Jensen B, Alvarez J, Gooley R, Smith J, Ibrahim R, Cartier R, Rovin J, Fujita T, Rutkin B, Yakubov S, Song H, Zahr F, Miyagawa S, Rajagopal V, Kauten J, Gada H, Mumtaz M, Bhindi R, Brady P, Batra S, Davis T, Iskander A, Heimansohn D, Hermiller J, Takamisawa I, Haldis T, Yamazaki S, Teirstein P, Tada N, Saito S, Merhi W, Leung S, Muller D, Heijmen R, Petrossian G, Robinson N, Knight P, Ling F, Radhakrishnan S, Fremes S, Lehr E, Gafoor S, Noel T, Walton A, Resar J, Adams D, Sharma S, Lilly S, Tadros P, Zorn G, Dauerman H, Ittleman F, Horlick E, Feindel C, Welt F, Sharma V, Markowitz A, Carroll J, Fullerton D, Griffith B, Gupta A, de Marchena E, Salerno T, Chetcuti S, Deeb G, Sultan I, Goel K, Pasupati S, Kon N, Zhao D, Ramlawi B, Forrest J. 3-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. Journal Of The American College Of Cardiology 2023, 81: 1663-1674. PMID: 36882136, DOI: 10.1016/j.jacc.2023.02.017.
• Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic StenosisShah N, Sugeng L, Zhang Z, Wang K, McNamara R, Agarwal V, Hur D, Lombo B, Bellumkonda L, Mankbadi M, Basem Dajani A, Forrest J, Krumholz H, Reinhardt S, Velazquez E, Faridi K. Variation in Reader-Reported Severity of Paradoxical Low-Flow Low-Gradient Aortic Stenosis. Journal Of The American Society Of Echocardiography 2023 PMID: 37995937, DOI: 10.1016/j.echo.2023.11.014.
• 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk TrialForrest J, Deeb G, Yakubov S, Gada H, Mumtaz M, Ramlawi B, Bajwa T, Teirstein P, Tchétché D, Huang J, Reardon M, Investigators E. 4-Year Outcomes of Patients With Aortic Stenosis in the Evolut Low Risk Trial. Journal Of The American College Of Cardiology 2023, 82: 2163-2165. PMID: 37877907, DOI: 10.1016/j.jacc.2023.09.813.
• TCT-133 Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic StenosisGrubb K, Lisko J, O’Hair D, Merhi W, Forrest J, Mahoney P, van Mieghem N, Windecker S, Yakubov S, Chetcuti S, Deeb G, Kleiman N, Althouse A, Reardon M. TCT-133 Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis. Journal Of The American College Of Cardiology 2023, 82: b52. DOI: 10.1016/j.jacc.2023.09.139.
• Severe aortic stenosis detection by deep learning applied to echocardiographyHolste G, Oikonomou E, Mortazavi B, Coppi A, Faridi K, Miller E, Forrest J, McNamara R, Ohno-Machado L, Yuan N, Gupta A, Ouyang D, Krumholz H, Wang Z, Khera R. Severe aortic stenosis detection by deep learning applied to echocardiography. European Heart Journal 2023, 44: 4592-4604. PMID: 37611002, DOI: 10.1093/eurheartj/ehad456.
• Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacementShah T, Maarek R, See C, Huang H, Wang Y, Parise H, Forrest J, Lansky A. Effect of antecedent statin usage on conduction disturbances and arrhythmias after transcatheter aortic valve replacement. Cardiovascular Revascularization Medicine 2023, 59: 3-8. PMID: 37573173, DOI: 10.1016/j.carrev.2023.07.022.
• Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy.Grubb K, Shekiladze N, Spencer J, Perdoncin E, Tang G, Xie J, Lisko J, Sanchez J, Lucas L, Sathananthan J, Rogers T, Deeb G, Fukuhara S, Blanke P, Leipsic J, Forrest J, Reardon M, Gleason P. Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy. EuroIntervention 2023, 19: e330-e339. PMID: 37067193, PMCID: PMC10333920, DOI: 10.4244/eij-d-22-01125.
• Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center StudySee C, Wang Y, Huang H, Parise H, Yang Y, Tirziu D, Francese D, Papoutsidakis N, Bader E, Kaple R, Cleman M, Lansky A, Forrest J. Impact of New-Onset Conduction Disturbances following Transcatheter Aortic Valve Replacement on Outcomes: A Single-Center Study. Journal Of Interventional Cardiology 2023, 2023: 5390338. PMID: 37292113, PMCID: PMC10247319, DOI: 10.1155/2023/5390338.
• Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosisIto S, Laham R, Nkomo V, Forrest J, Reardon M, Little S, Mumtaz M, Gada H, Bajwa T, Langholz D, Heiser J, Chawla A, Jenson B, Attizanni G, Markowitz A, Huang J, Oh J. Impact of aortic valve replacement in symptomatic low-risk patients with less than severe aortic stenosis. Open Heart 2023, 10: e002297. PMID: 37173100, PMCID: PMC10186477, DOI: 10.1136/openhrt-2023-002297.
• Cerebral Embolic Protection in Transcatheter Aortic Valve ReplacementIskander M, Jamil Y, Forrest J, Madhavan M, Makkar R, Leon M, Lansky A, Ahmad Y. Cerebral Embolic Protection in Transcatheter Aortic Valve Replacement. Structural Heart 2023, 7: 100169. PMID: 37520138, PMCID: PMC10382985, DOI: 10.1016/j.shj.2023.100169.
• Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform in a Real-World RegistryDallan L, Tang G, Forrest J, Reardon M, Szeto W, Kodali S, Baeza C, Eisenberg R, Attizzani G. Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform in a Real-World Registry. Circulation Cardiovascular Interventions 2023, 16: e012623. PMID: 36943929, PMCID: PMC10022658, DOI: 10.1161/circinterventions.122.012623.
• COMPUTED TOMOGRAPHY TO ASSESS FEASIBILITY OF CORONARY ACCESS FOLLOWING BALLOON-EXPANDABLE VALVE IMPLANTATION WITHIN A SUPRA-ANNULAR TRANSCATHETER VALVERogers T, Spencer J, Tang G, Grubb K, Gleason P, Gada H, Mahoney P, Dauerman H, Forrest J, Reardon M, Abdel-Wahab M, Puri R, Attizzani G, Caskey M, Chung C, Chen Y, Htun W, Sanchez J, Schwartz G, Popma J, Sathananthan J. COMPUTED TOMOGRAPHY TO ASSESS FEASIBILITY OF CORONARY ACCESS FOLLOWING BALLOON-EXPANDABLE VALVE IMPLANTATION WITHIN A SUPRA-ANNULAR TRANSCATHETER VALVE. Journal Of The American College Of Cardiology 2023, 81: 768. DOI: 10.1016/s0735-1097(23)01212-3.
• Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials.Ahmad Y, Howard J, Arnold A, Madhavan M, Cook C, Alu M, Mack M, Reardon M, Thourani V, Kapadia S, Thyregod H, Sondergaard L, Jørgensen T, Toff W, Van Mieghem N, Makkar R, Forrest J, Leon M. Transcatheter versus surgical aortic valve replacement in lower-risk and higher-risk patients: a meta-analysis of randomized trials. European Heart Journal 2023, 44: 836-852. PMID: 36660821, DOI: 10.1093/eurheartj/ehac642.
• Abstract 9462: Racial Disparities in Transcatheter and Surgical Aortic Valve Replacement Among Medicare Beneficiaries in the United States, 2012-2019Gupta A, Mori M, wang Y, Vahl T, Nazif T, Onuma O, Yong C, Sharma R, Kirtane A, Forrest J, George I, Kodali S, Chikwe J, Geirsson A, Makkar R, Leon M, Krumholz H. Abstract 9462: Racial Disparities in Transcatheter and Surgical Aortic Valve Replacement Among Medicare Beneficiaries in the United States, 2012-2019. Circulation 2022, 146: a9462-a9462. DOI: 10.1161/circ.146.suppl_1.9462.
• Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve DiseaseAhmad Y, Agarwal V, Williams M, Wang D, Reardon M, Cavalcante J, Makkar R, Forrest J. Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve Disease. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100506. DOI: 10.1016/j.jscai.2022.100506.
• Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the FutureAhmad Y, Madhavan M, Baron S, Forrest J, Borger M, Leipsic J, Cavalcante J, Wang D, McCarthy P, Szerlip M, Kapadia S, Makkar R, Mack M, Leon M, Cohen D. Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future. Structural Heart 2022, 7: 100102. PMID: 37275317, PMCID: PMC10236801, DOI: 10.1016/j.shj.2022.100102.
• Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal diseasePark DY, An S, Hanna JM, Wang SY, Cruz-Solbes AS, Kochar A, Lowenstern AM, Forrest JK, Ahmad Y, Cleman M, Damluji AA, Nanna MG. Readmission rates and risk factors for readmission after transcatheter aortic valve replacement in patients with end-stage renal disease. PLOS ONE 2022, 17: e0276394. PMID: 36264931, PMCID: PMC9584363, DOI: 10.1371/journal.pone.0276394.
• Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk TrialGada H, Vora AN, Tang GHL, Mumtaz M, Forrest JK, Laham RJ, Yakubov SJ, Deeb GM, Rammohan C, Huang J, Reardon MJ. Site-Level Variation and Predictors of Permanent Pacemaker Implantation Following TAVR in the Evolut Low-Risk Trial. Cardiovascular Revascularization Medicine 2022, 47: 48-54. PMID: 36266154, DOI: 10.1016/j.carrev.2022.10.004.
• Risk factors and mortality associated with permanent pacemaker after surgical or transcatheter aortic valve replacement: Early versus late implantationBin Mahmood SU, Mori M, Amabile A, Prescher L, Forrest J, Kaple R, Geirsson A, Mangi AA. Risk factors and mortality associated with permanent pacemaker after surgical or transcatheter aortic valve replacement: Early versus late implantation. Journal Of Cardiac Surgery 2022, 37: 4295-4300. PMID: 36131523, DOI: 10.1111/jocs.16938.
• TCT-494 The Evolut Supra-Annular, Self-Expanding Transcatheter Aortic Bioprosthesis Provides Symmetric Scaffolding for Leaflet Coaptation Despite Variable Annular MorphologyPuri R, Spencer J, Tchetche D, Forrest J, Reardon M, Sanchez J, Popma J, Tang G. TCT-494 The Evolut Supra-Annular, Self-Expanding Transcatheter Aortic Bioprosthesis Provides Symmetric Scaffolding for Leaflet Coaptation Despite Variable Annular Morphology. Journal Of The American College Of Cardiology 2022, 80: b200-b201. DOI: 10.1016/j.jacc.2022.08.583.
• Readmission and In-Hospital Outcomes After Transcatheter Aortic Valve Replacement in Patients With DementiaPark DY, Sana MK, Shoura S, Hammo H, Hu JR, Forrest JK, Lowenstern A, Cleman M, Ahmad Y, Nanna MG. Readmission and In-Hospital Outcomes After Transcatheter Aortic Valve Replacement in Patients With Dementia. Cardiovascular Revascularization Medicine 2022, 46: 70-77. PMID: 35973922, PMCID: PMC10940024, DOI: 10.1016/j.carrev.2022.08.016.
• Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled TrialsAhmad Y, Howard J, Seligman H, Arnold A, Madhavan M, Forrest J, Geirsson A, Mack M, Lansky A, Leon M. Early Surgery for Patients With Asymptomatic Severe Aortic Stenosis: A Meta-Analysis of Randomized Controlled Trials. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100383. DOI: 10.1016/j.jscai.2022.100383.
• C-50 | Association of Aortoventricular Angulation and Clinical Outcomes After Self-Expanding TAVRRogers T, Forrest J, Merhi W, Williams M, Bajwa T, Lambrecht L, Eisenberg R, Van Mieghem N, Reardon M, Waksman R. C-50 | Association of Aortoventricular Angulation and Clinical Outcomes After Self-Expanding TAVR. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100202. DOI: 10.1016/j.jscai.2022.100202.
• C-43 | Impact of Severe Patient-Prosthesis Mismatch in Women with Severe Aortic Stenosis Following Aortic Valve Replacement With a Self-Expanding, Supra-Annular Transcatheter Bioprosthesis or SurgeryMumtaz M, Satpathy R, Gada H, Forrest J, Van Mieghem N, Poulin M, Huang J, Zorn G, Reardon M. C-43 | Impact of Severe Patient-Prosthesis Mismatch in Women with Severe Aortic Stenosis Following Aortic Valve Replacement With a Self-Expanding, Supra-Annular Transcatheter Bioprosthesis or Surgery. Journal Of The Society For Cardiovascular Angiography & Interventions 2022, 1: 100195. DOI: 10.1016/j.jscai.2022.100195.
• Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid PatientsDeeb GM, Reardon MJ, Ramlawi B, Yakubov SJ, Chetcuti SJ, Kleiman NS, Mangi AA, Zahr F, Song HK, Gada H, Mumtaz M, Heiser J, Merhi W, Murrah CP, Noel T, Kirshner M, Byrne T, Ito S, Huang J, Forrest JK. Propensity-Matched 1-Year Outcomes Following Transcatheter Aortic Valve Replacement in Low-Risk Bicuspid and Tricuspid Patients. JACC Cardiovascular Interventions 2022, 15: 511-522. PMID: 35272776, DOI: 10.1016/j.jcin.2021.10.027.
• THE ROLE OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS: INSIGHTS FROM THE EVOLUT LOW RISK TRIALAnwaruddin S, Forrest J, Gada H, Mumtaz M, Huang J, Maini B, Oh J, Ito S, Kleiman N, Reardon M. THE ROLE OF TRANSCATHETER AORTIC VALVE REPLACEMENT IN LOW-FLOW, LOW-GRADIENT AORTIC STENOSIS: INSIGHTS FROM THE EVOLUT LOW RISK TRIAL. Journal Of The American College Of Cardiology 2022, 79: 653. DOI: 10.1016/s0735-1097(22)01644-8.
• Emergent Repair of Acute Type A Aortic Dissection From Transcatheter Aortic Valve ReplacementHameed I, Boix-Garibo R, Ahmed A, Forrest JK, Vallabhajosyula P. Emergent Repair of Acute Type A Aortic Dissection From Transcatheter Aortic Valve Replacement. Canadian Journal Of Cardiology 2022, 38: 404-406. PMID: 35031349, DOI: 10.1016/j.cjca.2022.01.003.
• Abstract 11543: Assessing Reporting of Low-Gradient Severe Aortic Stenosis Based on Race and Ethnicity: Observations from a Large Academic Health SystemShah N, Sugeng L, Wang K, McNamara R, Agarwal V, Hur D, Lombo B, Bellumkonda L, Forrest J, Krumholz H, Velazquez E, Faridi K. Abstract 11543: Assessing Reporting of Low-Gradient Severe Aortic Stenosis Based on Race and Ethnicity: Observations from a Large Academic Health System. Circulation 2021, 144: a11543-a11543. DOI: 10.1161/circ.144.suppl_1.11543.
• Abstract 11588: Variation in Reader-Reported Severity of Paradoxical Low-Flow Low Gradient Aortic Stenosis: Observations from AaLarge Academic Health SystemShah N, Sugeng L, Wang K, McNamara R, Agarwal V, Hur D, Lombo B, Bellumkonda L, Forrest J, Krumholz H, Velazquez E, Faridi K. Abstract 11588: Variation in Reader-Reported Severity of Paradoxical Low-Flow Low Gradient Aortic Stenosis: Observations from AaLarge Academic Health System. Circulation 2021, 144: a11588-a11588. DOI: 10.1161/circ.144.suppl_1.11588.
• TCT-147 Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the STS/ACC TVT RegistryDallan L, Tang G, Reardon M, Forrest J, Szeto W, Kodali S, Eisenberg R, Attizzani G. TCT-147 Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the STS/ACC TVT Registry. Journal Of The American College Of Cardiology 2021, 78: b60. DOI: 10.1016/j.jacc.2021.09.997.
• TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized StudiesVora A, Gada H, Sherwood M, Lopes R, Forrest J, Huang J, Reardon M. TCT-48 Incidence and Outcomes of Atrial Fibrillation in Patients Undergoing TAVR Versus SAVR: Experience From SURTAVI and Low-Risk Randomized Studies. Journal Of The American College Of Cardiology 2021, 78: b19. DOI: 10.1016/j.jacc.2021.09.898.
• Coronary Revascularization in Patients Undergoing Aortic Valve Replacement for Severe Aortic StenosisPatel KP, Michail M, Treibel TA, Rathod K, Jones DA, Ozkor M, Kennon S, Forrest JK, Mathur A, Mullen MJ, Lansky A, Baumbach A. Coronary Revascularization in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis. JACC Cardiovascular Interventions 2021, 14: 2083-2096. PMID: 34620388, DOI: 10.1016/j.jcin.2021.07.058.
• Redo‐transcatheter aortic valve replacement with the supra‐annular, self‐expandable Evolut platform: Insights from the Transcatheter valve Therapy RegistryAttizzani GF, Dallan LAP, Forrest JK, Reardon MJ, Szeto WY, Liu F, Pelletier M. Redo‐transcatheter aortic valve replacement with the supra‐annular, self‐expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry. Catheterization And Cardiovascular Interventions 2021, 99: 869-876. PMID: 34533891, DOI: 10.1002/ccd.29941.
• Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy RegistryDallan LAP, Forrest JK, Reardon MJ, Szeto WY, George I, Kodali S, Kleiman NS, Yakubov SJ, Grubb KJ, Liu F, Baeza C, Attizzani GF. Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry. Journal Of The American Heart Association 2021, 10: e021871. PMID: 34514840, PMCID: PMC8649494, DOI: 10.1161/jaha.121.021871.
• Alternate accesses for transcatheter aortic valve replacement: A network meta‐analysisHameed I, Oakley CT, Hameed NUF, Ahmed A, Naeem N, Singh S, Rizwana K, Brackett A, Forrest JK, Kaple R, Mangi A, Salemi A, Geirsson A, Gaudino M, Vallabhajosyula P. Alternate accesses for transcatheter aortic valve replacement: A network meta‐analysis. Journal Of Cardiac Surgery 2021, 36: 4308-4319. PMID: 34494307, DOI: 10.1111/jocs.15961.
• International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes.Michelena HI, Della Corte A, Evangelista A, Maleszewski JJ, Edwards WD, Roman MJ, Devereux RB, Fernández B, Asch FM, Barker AJ, Sierra-Galan LM, De Kerchove L, Fernandes SM, Fedak PWM, Girdauskas E, Delgado V, Abbara S, Lansac E, Prakash SK, Bissell MM, Popescu BA, Hope MD, Sitges M, Thourani VH, Pibarot P, Chandrasekaran K, Lancellotti P, Borger MA, Forrest JK, Webb J, Milewicz DM, Makkar R, Leon MB, Sanders SP, Markl M, Ferrari VA, Roberts WC, Song JK, Blanke P, White CS, Siu S, Svensson LG, Braverman AC, Bavaria J, Sundt TM, El Khoury G, De Paulis R, Enriquez-Sarano M, Bax JJ, Otto CM, Schäfers HJ. International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. The Annals Of Thoracic Surgery 2021, 112: e203-e235. PMID: 34304860, DOI: 10.1016/j.athoracsur.2020.08.119.
• Summary: International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes.Michelena HI, Della Corte A, Evangelista A, Maleszewski JJ, Edwards WD, Roman MJ, Devereux RB, Fernández B, Asch FM, Barker AJ, Sierra-Galan LM, De Kerchove L, Fernandes SM, Fedak PWM, Girdauskas E, Delgado V, Abbara S, Lansac E, Prakash SK, Bissell MM, Popescu BA, Hope MD, Sitges M, Thourani VH, Pibarot P, Chandrasekaran K, Lancellotti P, Borger MA, Forrest JK, Webb J, Milewicz DM, Makkar R, Leon MB, Sanders SP, Markl M, Ferrari VA, Roberts WC, Song JK, Blanke P, White CS, Siu S, Svensson LG, Braverman AC, Bavaria J, Sundt TM, El Khoury G, De Paulis R, Enriquez-Sarano M, Bax JJ, Otto CM, Schäfers HJ. Summary: International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. The Annals Of Thoracic Surgery 2021, 112: 1005-1022. PMID: 34304861, DOI: 10.1016/j.athoracsur.2021.05.001.
• The Dos and Don'ts of Mitral Valve-in-Valve and Valve-in-Ring.Simonato M, Forrest JK, Dvir D. The Dos and Don'ts of Mitral Valve-in-Valve and Valve-in-Ring. Innovations (Philadelphia, Pa.) 2021, 16: 402-408. PMID: 34839722, DOI: 10.1177/15569845211048940.
• International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research PurposesMichelena HI, Corte AD, Evangelista A, Maleszewski JJ, Edwards WD, Roman MJ, Devereux RB, Fernández B, Asch FM, Barker AJ, Sierra-Galan LM, De Kerchove L, Fernandes SM, Fedak PWM, Girdauskas E, Delgado V, Abbara S, Lansac E, Prakash SK, Bissell MM, Popescu BA, Hope MD, Sitges M, Thourani VH, Pibarot P, Chandrasekaran K, Lancellotti P, Borger MA, Forrest JK, Webb J, Milewicz DM, Makkaar R, Leon MB, Sanders SP, Markl M, Ferrari VA, Roberts WC, Song JK, Blanke P, White CS, Siu S, Svensson LG, Braverman AC, Bavaria J, Sundt TM, El Khoury G, De Paulis R, Enriquez-Sarano M, Bax JJ, Otto CM, Schäfers HJ. International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy, for Clinical, Surgical, Interventional and Research Purposes. Radiology Cardiothoracic Imaging 2021, 3: e200496. PMID: 34505060, PMCID: PMC8424700, DOI: 10.1148/ryct.2021200496.
• Impact of Persistent vs. Transient Conduction Abnormalities Within 7 Days Post-TAVR on Mortality: Results of a Single-Center Prospective RegistrySee C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. Impact of Persistent vs. Transient Conduction Abnormalities Within 7 Days Post-TAVR on Mortality: Results of a Single-Center Prospective Registry. Cardiovascular Revascularization Medicine 2021, 28: s43. DOI: 10.1016/j.carrev.2021.06.099.
• A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial.Lansky AJ, Makkar R, Nazif T, Messé S, Forrest J, Sharma R, Schofer J, Linke A, Brown D, Dhoble A, Horwitz P, Zang M, DeMarco F, Rajagopal V, Dwyer MG, Zivadinov R, Stella P, Rovin J, Parise H, Kodali S, Baumbach A, Moses J. A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial. European Heart Journal 2021, 42: 2670-2679. PMID: 34000004, DOI: 10.1093/eurheartj/ehab213.
• Composite Metric for Benchmarking Site Performance in Transcatheter Aortic Valve ReplacementDesai ND, O’Brien S, Cohen DJ, Carroll J, Vemulapalli S, Arnold SV, Forrest JK, Thourani VH, Kirtane AJ, O’Neil B, Manandhar P, Shahian DM, Badhwar V, Bavaria JE. Composite Metric for Benchmarking Site Performance in Transcatheter Aortic Valve Replacement. Circulation 2021, 144: 186-194. PMID: 33947202, DOI: 10.1161/circulationaha.120.051456.
• IMPACT OF SEX ON OUTCOMES IN TAVR: RESULTS FROM A SINGLE CENTER PROSPECTIVE REGISTRYWang Y, Yang Y, See C, tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. IMPACT OF SEX ON OUTCOMES IN TAVR: RESULTS FROM A SINGLE CENTER PROSPECTIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 900. DOI: 10.1016/s0735-1097(21)02259-2.
• IMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRYSee C, Wang Y, Yang Y, Tirziu D, Papoutsidakis N, Kaple R, Cleman M, Lansky A, Forrest J. IMPACT OF PACEMAKER IMPLANT ≤ 30 DAYS POST TAVR ON MORTALITY: RESULTS OF A SINGLE CENTER PROSPECTIVE REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 974. DOI: 10.1016/s0735-1097(21)02333-0.
• AN ENDOSCOPICALLY GUIDED TRANSESOPHAGEAL ECHOCARDIOGRAM-A NOVEL APPROACH TO TRANSCATHETER MITRAL VALVE REPAIR IN THE SETTING OF A ZENKER'S DIVERTICULUMTangel R, Agarwal V, Forrest J, Cleman M, Kaple R, Singh P, Mehta H, Hughes M, Tarangelo N, Muniraj T, DaSilva P, Balan S. AN ENDOSCOPICALLY GUIDED TRANSESOPHAGEAL ECHOCARDIOGRAM-A NOVEL APPROACH TO TRANSCATHETER MITRAL VALVE REPAIR IN THE SETTING OF A ZENKER'S DIVERTICULUM. Journal Of The American College Of Cardiology 2021, 77: 2457. DOI: 10.1016/s0735-1097(21)03812-2.
• NATIONAL TRENDS OF PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS FROM THE STS/ACC TVT REGISTRYChau K, George I, Vemulapalli S, Wegermann Z, Forrest J, Yakubov S, Williams M, Manandhar P, Vahl T, Leon M, Kodali S, Kirtane A, Nazif T. NATIONAL TRENDS OF PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT: AN ANALYSIS FROM THE STS/ACC TVT REGISTRY. Journal Of The American College Of Cardiology 2021, 77: 918. DOI: 10.1016/s0735-1097(21)02277-4.
• IMPACT OF SURGICAL AND TRANSCATHETER AORTIC VALVE REPLACEMENT IN SYMPTOMATIC PATIENTS OF LOW-GRADIENT AORTIC STENOSIS WITH DOPPLER VELOCITY INDEX GREATER THAN 0.25Ito S, Laham R, Nkomo V, Forrest J, Reardon M, Little S, Landholz D, Oh J. IMPACT OF SURGICAL AND TRANSCATHETER AORTIC VALVE REPLACEMENT IN SYMPTOMATIC PATIENTS OF LOW-GRADIENT AORTIC STENOSIS WITH DOPPLER VELOCITY INDEX GREATER THAN 0.25. Journal Of The American College Of Cardiology 2021, 77: 1760. DOI: 10.1016/s0735-1097(21)03116-8.
• Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement From the STS/ACC TVT RegistryTang GHL, Sengupta A, Alexis SL, Bapat VN, Adams DH, Sharma SK, Kini AS, Kodali SK, Ramlawi B, Gada H, Vora AN, Forrest JK, Kaple RK, Liu F, Reardon MJ. Outcomes of Prosthesis-Patient Mismatch Following Supra-Annular Transcatheter Aortic Valve Replacement From the STS/ACC TVT Registry. JACC Cardiovascular Interventions 2021, 14: 964-976. PMID: 33958170, DOI: 10.1016/j.jcin.2021.03.040.
• Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement REFLECT IINazif TM, Moses J, Sharma R, Dhoble A, Rovin J, Brown D, Horwitz P, Makkar R, Stoler R, Forrest J, Messé S, Dickerman S, Brennan J, Zivadinov R, Dwyer MG, Lansky AJ, Investigators R. Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement REFLECT II. JACC Cardiovascular Interventions 2021, 14: 515-527. PMID: 33663779, DOI: 10.1016/j.jcin.2020.11.011.
• A Case of Presyncope After Transcatheter Aortic Valve ReplacementWorkman V, Forrest JK, Enriquez A. A Case of Presyncope After Transcatheter Aortic Valve Replacement. Circulation 2021, 143: 857-861. PMID: 33617312, DOI: 10.1161/circulationaha.120.049693.
• Planning for the Next Transcatheter Aortic Valve Replacement Starts Today.Cavender MA, Forrest JK. Planning for the Next Transcatheter Aortic Valve Replacement Starts Today. Circulation. Cardiovascular Interventions 2020, 13: e010226. PMID: 33272033, DOI: 10.1161/CIRCINTERVENTIONS.120.010226.
• Three-Year Outcomes With a Contemporary Self-Expanding Transcatheter Valve From the Evolut PRO US Clinical StudyWyler von Ballmoos MC, Reardon MJ, Williams MR, Mangi AA, Kleiman NS, Yakubov SJ, Watson D, Kodali S, George I, Tadros P, Zorn GL, Brown J, Kipperman R, Oh JK, Qiao H, Forrest JK. Three-Year Outcomes With a Contemporary Self-Expanding Transcatheter Valve From the Evolut PRO US Clinical Study. Cardiovascular Revascularization Medicine 2020, 26: 12-16. PMID: 33199247, DOI: 10.1016/j.carrev.2020.11.007.
• TCT CONNECT-107 Poor Survival in Patients With Aortic Stenosis Without InterventionYousef S, Same H, Mori M, Agarwal R, Singh S, Brooks C, Mena-Hurtado C, Smolderen K, Nagpal S, Cleman M, Forrest J, Kaple R, Zhang Y, Assi R, Geirsson A. TCT CONNECT-107 Poor Survival in Patients With Aortic Stenosis Without Intervention. Journal Of The American College Of Cardiology 2020, 76: b47-b48. DOI: 10.1016/j.jacc.2020.09.121.
• TCT CONNECT-112 Intervention Management Strategies and Association With Long-Term Mortality in Patients With Concomitant Aortic Valve Stenosis and Coronary Artery DiseaseYousef S, Mori M, Assi R, Smolderen K, Kaple R, Forrest J, Cleman M, Mena-Hurtado C, Geirsson A, Vallabhajosyula P. TCT CONNECT-112 Intervention Management Strategies and Association With Long-Term Mortality in Patients With Concomitant Aortic Valve Stenosis and Coronary Artery Disease. Journal Of The American College Of Cardiology 2020, 76: b50. DOI: 10.1016/j.jacc.2020.09.126.
• TCT CONNECT-87 Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT RegistryAttizzani G, Dallan L, Pelletier M, Deeb G, Forrest J, Reardon M, Popma J. TCT CONNECT-87 Redo Transcatheter Aortic Valve Replacement With the Supra-Annular, Self-Expandable Evolut Platform: Insights From the TVT Registry. Journal Of The American College Of Cardiology 2020, 76: b38-b39. DOI: 10.1016/j.jacc.2020.09.101.
• Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable ValveAttizzani GF, Dallan LAP, Markowitz A, Yakubov SJ, Deeb GM, Reardon MJ, Forrest JK, Mangi AA, Huang J, Popma JJ. Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve. JACC Cardiovascular Interventions 2020, 13: 1816-1824. PMID: 32763073, DOI: 10.1016/j.jcin.2020.04.028.
• MULTICENTER EVALUATION OF QUALITY OF LIFE IN PATIENTS WITH PARADOXICAL LOW-FLOW, LOW-GRADIENT UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (PLO-FLOW TAVR STUDY)Hirji S, Kaneko T, McGurk S, Cherkasky O, Ahmed H, Wong S, Salemi A, Kampaktsis P, Kaple R, Forrest J, Kini A, Malarczyk A, Kiehm S, Percy E, Harloff M, Yazdchi F, Shah P, Tang G. MULTICENTER EVALUATION OF QUALITY OF LIFE IN PATIENTS WITH PARADOXICAL LOW-FLOW, LOW-GRADIENT UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT (PLO-FLOW TAVR STUDY). Journal Of The American College Of Cardiology 2020, 75: 1488. DOI: 10.1016/s0735-1097(20)32115-x.
• TAVR in Low-Risk Patients FDA Approval, the New NCD, and Shared Decision-MakingCoylewright M, Forrest JK, McCabe JM, Nazif TM. TAVR in Low-Risk Patients FDA Approval, the New NCD, and Shared Decision-Making. Journal Of The American College Of Cardiology 2020, 75: 1208-1211. PMID: 32164894, DOI: 10.1016/j.jacc.2019.12.057.
• Adjunctive Antithrombotic Therapy for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve ReplacementSaito Y, Nazif T, Baumbach A, Tchétché D, Latib A, Kaple R, Forrest J, Prendergast B, Lansky A. Adjunctive Antithrombotic Therapy for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. JAMA Cardiology 2020, 5: 92-101. PMID: 31721980, DOI: 10.1001/jamacardio.2019.4367.
• Three Generations of Self-Expanding Transcatheter Aortic Valves A Report From the STS/ACC TVT RegistryForrest JK, Kaple RK, Tang GHL, Yakubov SJ, Nazif TM, Williams MR, Zhang A, Popma JJ, Reardon MJ. Three Generations of Self-Expanding Transcatheter Aortic Valves A Report From the STS/ACC TVT Registry. JACC Cardiovascular Interventions 2020, 13: 170-179. PMID: 31973793, DOI: 10.1016/j.jcin.2019.08.035.
• TCT-763 Valve in Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement: Real World Outcomes From the National Inpatient Sample (2013–2016)Kim G, Geirsson A, Cleman M, Forrest J, Kaple R. TCT-763 Valve in Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement: Real World Outcomes From the National Inpatient Sample (2013–2016). Journal Of The American College Of Cardiology 2019, 74: b748. DOI: 10.1016/j.jacc.2019.08.902.
• TCT-752 Incidence and Outcomes of Patient-Prosthesis Mismatch Following Self-Expanding Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT RegistryTang G, Bapat V, Popma J, Adams D, Kodali S, Ramlawi B, Gada H, Forrest J, Kaple R, Reardon M. TCT-752 Incidence and Outcomes of Patient-Prosthesis Mismatch Following Self-Expanding Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry. Journal Of The American College Of Cardiology 2019, 74: b738. DOI: 10.1016/j.jacc.2019.08.890.
• The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventionsNazif TM, Chen S, Codner P, Grossman PM, Menees DS, Sanchez CE, Yakubov SJ, White J, Kapadia S, Whisenant BK, Forrest JK, Krishnaswamy A, Arshi A, Orford JL, Leon MB, Dizon JM, Kodali SK, Chetcuti SJ. The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions. Catheterization And Cardiovascular Interventions 2019, 95: 1051-1056. PMID: 31478304, DOI: 10.1002/ccd.28476.
• Predictors and Risk Calculator of Early Unplanned Hospital Readmission Following Contemporary Self-Expanding Transcatheter Aortic Valve Replacement from the STS/ACC TVT RegistrySanchez CE, Hermiller JB, Pinto DS, Chetcuti SJ, Arshi A, Forrest JK, Huang J, Yakubov SJ. Predictors and Risk Calculator of Early Unplanned Hospital Readmission Following Contemporary Self-Expanding Transcatheter Aortic Valve Replacement from the STS/ACC TVT Registry. Cardiovascular Revascularization Medicine 2019, 21: 263-270. PMID: 31255552, DOI: 10.1016/j.carrev.2019.05.032.
• Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients.Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O'Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS, Askew J, Sorajja P, Rovin J, Chetcuti SJ, Adams DH, Teirstein PS, Zorn GL, Forrest JK, Tchétché D, Resar J, Walton A, Piazza N, Ramlawi B, Robinson N, Petrossian G, Gleason TG, Oh JK, Boulware MJ, Qiao H, Mugglin AS, Reardon MJ. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. The New England Journal Of Medicine 2019, 380: 1706-1715. PMID: 30883053, DOI: 10.1056/NEJMoa1816885.
• BUNDLE BRANCH REENTRANT VENTRICULAR TACHYCARDIA AFTER TRANSCATHETER AORTIC VALVE REPLACEMENTWorkman V, Freeman J, Forrest J, Upadhyaya K, Carney K, Enriquez A. BUNDLE BRANCH REENTRANT VENTRICULAR TACHYCARDIA AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT. Journal Of The American College Of Cardiology 2019, 73: 2934. DOI: 10.1016/s0735-1097(19)33540-5.
• 600.03 Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTMForrest J, Ramlawi B, Popma J, Reardon M. 600.03 Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Bicuspid Morphology: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryTM. JACC Cardiovascular Interventions 2019, 12: s43. DOI: 10.1016/j.jcin.2019.01.155.
• Cardiac Biomarkers in Transcatheter Aortic Valve ImplantationHermany P, Forrest J. Cardiac Biomarkers in Transcatheter Aortic Valve Implantation. 2019, 147-164. DOI: 10.1007/978-3-030-05912-5_13.
• Gender-Related Differences in Transcatheter Aortic Valve ImplantationStair B, Forrest J. Gender-Related Differences in Transcatheter Aortic Valve Implantation. 2019, 189-200. DOI: 10.1007/978-3-030-05912-5_16.
• Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacementMori M, Bin Mahmood SU, Geirsson A, Yun JJ, Cleman MW, Forrest JK, Mangi AA. Trends in volume and risk profiles of patients undergoing isolated surgical and transcatheter aortic valve replacement. Catheterization And Cardiovascular Interventions 2018, 93: e337-e342. PMID: 30269424, DOI: 10.1002/ccd.27855.
• TCT-184 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with The Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT RegistryForrest J, Williams M, Popma J, Reardon M. TCT-184 30-Day Outcomes Following Transcatheter Aortic Valve Replacement with The Evolut PRO Valve in Commercial Use: Report from the STS/ACC TVT Registry. Journal Of The American College Of Cardiology 2018, 72: b78. DOI: 10.1016/j.jacc.2018.08.1299.
• Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999–2014Goldsweig AM, Wang Y, Forrest JK, Cleman MW, Minges KE, Mangi AA, Aronow HD, Krumholz HM, Curtis JP. Ventricular septal rupture complicating acute myocardial infarction: Incidence, treatment, and outcomes among medicare beneficiaries 1999–2014. Catheterization And Cardiovascular Interventions 2018, 92: 1104-1115. PMID: 29513365, DOI: 10.1002/ccd.27576.
• ANALYSIS OF THE INITIAL UNITED STATES EXPERIENCE WITH THE BIOTRACE TEMPO TEMPORARY PACING LEAD IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AND OTHER CARDIAC PROCEDURESNazif T, Sanchez C, Whisenant B, Forrest J, Yakubov S, Grossman P, Arshi A, Menees D, Terre J, Orford J, Leon M, Kodali S, Chetcuti S. ANALYSIS OF THE INITIAL UNITED STATES EXPERIENCE WITH THE BIOTRACE TEMPO TEMPORARY PACING LEAD IN TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) AND OTHER CARDIAC PROCEDURES. Journal Of The American College Of Cardiology 2018, 71: a1285. DOI: 10.1016/s0735-1097(18)31826-6.
• UTILIZATION OF DOBUTAMINE STRESS STUDIES IN PATIENTS WITH SYMPTOMATIC, SEVERE LOW-FLOW/LOW-GRADIENT AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENTChowdhury M, Trejo M, Lombo B, Forrest J, Lin B, Sugeng L. UTILIZATION OF DOBUTAMINE STRESS STUDIES IN PATIENTS WITH SYMPTOMATIC, SEVERE LOW-FLOW/LOW-GRADIENT AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT. Journal Of The American College Of Cardiology 2018, 71: a1326. DOI: 10.1016/s0735-1097(18)31867-9.
• TCT-478 Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial WrapForrest J, Williams M. TCT-478 Low Incidence of Paravalvular Leak at 6 Months with the New Self-Expanding Repositionable Transcatheter Aortic Valve with Pericardial Wrap. Journal Of The American College Of Cardiology 2017, 70: b198. DOI: 10.1016/j.jacc.2017.09.592.
• Biomarkers in Transcatheter Aortic Valve Replacement Prevalent, But Are They Prognostic?∗Forrest JK, Hermany PL. Biomarkers in Transcatheter Aortic Valve Replacement Prevalent, But Are They Prognostic?∗. JACC Cardiovascular Interventions 2017, 10: 1561-1563. PMID: 28797434, DOI: 10.1016/j.jcin.2017.06.043.
• The SURTAVI study: TAVI for patients with intermediate risk.Jones DA, Tchétché D, Forrest J, Hellig F, Lansky A, Moat N. The SURTAVI study: TAVI for patients with intermediate risk. EuroIntervention 2017, 13: e617-e620. PMID: 28781252, DOI: 10.4244/eijv13i5a97.
• 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical BioprosthesesDeeb GM, Chetcuti SJ, Reardon MJ, Patel HJ, Grossman PM, Schreiber T, Forrest JK, Bajwa TK, O’Hair D, Petrossian G, Robinson N, Katz S, Hartman A, Dauerman HL, Schmoker J, Khabbaz K, Watson DR, Yakubov SJ, Oh JK, Li S, Kleiman NS, Adams DH, Popma JJ. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses. JACC Cardiovascular Interventions 2017, 10: 1034-1044. PMID: 28521921, DOI: 10.1016/j.jcin.2017.03.018.
• Proposed Standardized Neurological Endpoints for Cardiovascular Clinical TrialsAn Academic Research Consortium InitiativeLansky AJ, Messé SR, Brickman AM, Dwyer M, van der Worp H, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Moy C, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical TrialsAn Academic Research Consortium Initiative. European Heart Journal 2017, 39: 1687-1697. PMID: 28171522, PMCID: PMC6251670, DOI: 10.1093/eurheartj/ehx037.
• Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials An Academic Research Consortium InitiativeLansky AJ, Messé SR, Brickman AM, Dwyer M, van der Worp HB, Lazar RM, Pietras CG, Abrams KJ, McFadden E, Petersen NH, Browndyke J, Prendergast B, Ng VG, Cutlip DE, Kapadia S, Krucoff MW, Linke A, Moy CS, Schofer J, van Es GA, Virmani R, Popma J, Parides MK, Kodali S, Bilello M, Zivadinov R, Akar J, Furie KL, Gress D, Voros S, Moses J, Greer D, Forrest JK, Holmes D, Kappetein AP, Mack M, Baumbach A. Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials An Academic Research Consortium Initiative. Journal Of The American College Of Cardiology 2017, 69: 679-691. PMID: 28183511, DOI: 10.1016/j.jacc.2016.11.045.
• Low incidence of paravalvular leak at 6 months with the new self-expanding repositionable transcatheter aortic valve with pericardial wrap.Forrest JK, Williams M. Low incidence of paravalvular leak at 6 months with the new self-expanding repositionable transcatheter aortic valve with pericardial wrap [abstract]. Journal of the American College of Cardiology 2017, 70(18), Supplement B:198.
• Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial)Lansky AJ, Brown D, Pena C, Pietras CG, Parise H, Ng VG, Meller S, Abrams KJ, Cleman M, Margolis P, Petrossian G, Brickman AM, Voros S, Moses J, Forrest JK. Neurologic Complications of Unprotected Transcatheter Aortic Valve Implantation (from the Neuro-TAVI Trial). The American Journal Of Cardiology 2016, 118: 1519-1526. PMID: 27645761, DOI: 10.1016/j.amjcard.2016.08.013.
• Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve ReplacementPopma JJ, Gleason TG, Yakubov SJ, Harrison JK, Forrest JK, Maini B, Ruiz CE, Pinto DS, Costa M, Resar J, Conte J, Crestanello J, Chang Y, Oh JK, Reardon MJ, Adams DH. Relationship of Annular Sizing Using Multidetector Computed Tomographic Imaging and Clinical Outcomes After Self-Expanding CoreValve Transcatheter Aortic Valve Replacement. Circulation Cardiovascular Interventions 2016, 9: e003282. PMID: 27369803, DOI: 10.1161/circinterventions.115.003282.
• Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial)Skelding KA, Yakubov SJ, Kleiman NS, Reardon MJ, Adams DH, Huang J, Forrest JK, Popma JJ. Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial). The American Journal Of Cardiology 2016, 118: 560-566. PMID: 27381665, DOI: 10.1016/j.amjcard.2016.05.051.
• Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials)Forrest JK, Adams DH, Popma JJ, Reardon MJ, Deeb GM, Yakubov SJ, Hermiller JB, Huang J, Skelding KA, Lansky A. Transcatheter Aortic Valve Replacement in Women Versus Men (from the US CoreValve Trials). The American Journal Of Cardiology 2016, 118: 396-402. PMID: 27346591, DOI: 10.1016/j.amjcard.2016.05.013.
• Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011)Arora S, Panaich SS, Patel N, Patel NJ, Lahewala S, Thakkar B, Savani C, Jhamnani S, Singh V, Patel N, Patel S, Sonani R, Patel A, Tripathi B, Deshmukh A, Chothani A, Patel J, Bhatt P, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Mena CI, Schreiber T, Grines C, Cleman M, Forrest JK, Badheka AO. Impact of Glycoprotein IIb/IIIa Inhibitors Use on Outcomes After Lower Extremity Endovascular Interventions From Nationwide Inpatient Sample (2006–2011). Catheterization And Cardiovascular Interventions 2016, 88: 605-616. PMID: 26914274, DOI: 10.1002/ccd.26452.
• Influence of hospital volume and outcomes of adult structural heart proceduresPanaich SS, Patel N, Arora S, Patel NJ, Patel SV, Savani C, Singh V, Sonani R, Deshmukh A, Cleman M, Mangi A, Forrest JK, Badheka AO. Influence of hospital volume and outcomes of adult structural heart procedures. World Journal Of Cardiology 2016, 8: 302-309. PMID: 27152142, PMCID: PMC4840163, DOI: 10.4330/wjc.v8.i4.302.
• Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosisThakkar B, Patel A, Mohamad B, Patel NJ, Bhatt P, Bhimani R, Patel A, Arora S, Savani C, Solanki S, Sonani R, Patel S, Patel N, Deshmukh A, Mohamad T, Grines C, Cleman M, Mangi A, Forrest J, Badheka AO. Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis. Catheterization And Cardiovascular Interventions 2015, 87: 955-962. PMID: 26699085, DOI: 10.1002/ccd.26345.
• Intravascular Ultrasound in Lower Extremity Peripheral Vascular InterventionsPanaich SS, Arora S, Patel N, Patel NJ, Savani C, Patel A, Thakkar B, Singh V, Patel S, Patel N, Agnihotri K, Bhatt P, Deshmukh A, Gupta V, Attaran RR, Mena CI, Grines CL, Cleman M, Forrest JK, Badheka AO. Intravascular Ultrasound in Lower Extremity Peripheral Vascular Interventions. Journal Of Endovascular Therapy 2015, 23: 65-75. PMID: 26637836, DOI: 10.1177/1526602815620780.
• Effect of Hospital Volume on Outcomes of Transcatheter Mitral Valve Repair: An Early US ExperiencePatel NJ, Badheka AO, Jhamnani S, Panaich SS, Singh V, Patel N, Arora S, Grines CL, Cleman M, Forrest JK. Effect of Hospital Volume on Outcomes of Transcatheter Mitral Valve Repair: An Early US Experience. Journal Of Interventional Cardiology 2015, 28: 464-471. PMID: 26489974, DOI: 10.1111/joic.12228.
• TCT-623 Transcatheter Aortic Valve Replacement In Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access TrialsForrest J, Lansky A, Maini B, Skelding K, Casale A, Fail P, Popma J. TCT-623 Transcatheter Aortic Valve Replacement In Women Versus Men: An Analysis of the CoreValve US Pivotal and Continued Access Trials. Journal Of The American College Of Cardiology 2015, 66: b254-b255. DOI: 10.1016/j.jacc.2015.08.642.
• TCT-191 Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Replacement: A Multicenter experienceSingh V, Patel S, Patel N, Savani C, Patel N, Arora S, Panaich S, Cleman M, Mangi A, Forrest J, Badheka A. TCT-191 Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Replacement: A Multicenter experience. Journal Of The American College Of Cardiology 2015, 66: b72. DOI: 10.1016/j.jacc.2015.08.205.
• Impact of Hospital Volume on Outcomes of Endovascular Stenting for Adult Aortic CoarctationBhatt P, Patel NJ, Patel A, Sonani R, Patel A, Panaich SS, Thakkar B, Savani C, Jhamnani S, Patel N, Patel N, Pant S, Patel S, Arora S, Dave A, Singh V, Chothani A, Patel J, Ansari M, Deshmukh A, Bhimani R, Grines C, Cleman M, Mangi A, Forrest JK, Badheka AO. Impact of Hospital Volume on Outcomes of Endovascular Stenting for Adult Aortic Coarctation. The American Journal Of Cardiology 2015, 116: 1418-1424. PMID: 26471501, DOI: 10.1016/j.amjcard.2015.07.066.
• Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Implantation (from the National Inpatient Sample)Singh V, Patel SV, Savani C, Patel NJ, Patel N, Arora S, Panaich SS, Deshmukh A, Cleman M, Mangi A, Forrest JK, Badheka AO. Mechanical Circulatory Support Devices and Transcatheter Aortic Valve Implantation (from the National Inpatient Sample). The American Journal Of Cardiology 2015, 116: 1574-1580. PMID: 26434512, DOI: 10.1016/j.amjcard.2015.08.020.
• Comparison of Inhospital Outcomes of Surgical Aortic Valve Replacement in Hospitals With and Without Availability of a Transcatheter Aortic Valve Implantation Program (from a Nationally Representative Database)Singh V, Badheka AO, Patel SV, Patel NJ, Thakkar B, Patel N, Arora S, Patel N, Patel A, Savani C, Ghatak A, Panaich SS, Jhamnani S, Deshmukh A, Chothani A, Sonani R, Patel A, Bhatt P, Dave A, Bhimani R, Mohamad T, Grines C, Cleman M, Forrest JK, Mangi A. Comparison of Inhospital Outcomes of Surgical Aortic Valve Replacement in Hospitals With and Without Availability of a Transcatheter Aortic Valve Implantation Program (from a Nationally Representative Database). The American Journal Of Cardiology 2015, 116: 1229-1236. PMID: 26297512, DOI: 10.1016/j.amjcard.2015.07.039.
• Transcatheter pulmonary valve implantation: A cross-sectional US experiencePatel A, Patel A, Bhatt P, Savani C, Thakkar B, Sonani R, Patel NJ, Arora S, Panaich S, Singh V, Patel S, Pant S, Ansari MM, Deshmukh A, Patel N, Dave A, Grines C, Cleman M, Forrest JK, Badheka AO. Transcatheter pulmonary valve implantation: A cross-sectional US experience. International Journal Of Cardiology 2015, 199: 186-188. PMID: 26197405, DOI: 10.1016/j.ijcard.2015.07.021.
• Vaccination Serology Status and Cardiovascular Mortality: Insight from NHANES III and Continuous NHANESChothani A, Shah N, Patel NJ, Deshmukh A, Singh V, Patel N, Panaich SS, Arora S, Patel A, Savani C, Thakkar B, Bhatt P, Cohen MG, Grines C, Forrest JK, Badheka AO. Vaccination Serology Status and Cardiovascular Mortality: Insight from NHANES III and Continuous NHANES. Postgraduate Medicine 2015, 127: 561-564. PMID: 26174358, DOI: 10.1080/00325481.2015.1064300.
• Multivessel Percutaneous Coronary Interventions in the United StatesArora S, Panaich SS, Patel NJ, Patel N, Solanki S, Deshmukh A, Singh V, Lahewala S, Savani C, Thakkar B, Dave A, Patel A, Bhatt P, Sonani R, Patel A, Cleman M, Forrest JK, Schreiber T, Badheka AO, Grines C. Multivessel Percutaneous Coronary Interventions in the United States. Angiology 2015, 67: 326-335. PMID: 26145455, DOI: 10.1177/0003319715593853.
• Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011])Arora S, Panaich SS, Patel N, Patel N, Lahewala S, Solanki S, Patel P, Patel A, Manvar S, Savani C, Tripathi B, Thakkar B, Jhamnani S, Singh V, Patel S, Patel J, Bhimani R, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Grines C, Mena CI, Cleman M, Forrest J, Badheka AO. Impact of Hospital Volume on Outcomes of Lower Extremity Endovascular Interventions (Insights from the Nationwide Inpatient Sample [2006 to 2011]). The American Journal Of Cardiology 2015, 116: 791-800. PMID: 26100585, DOI: 10.1016/j.amjcard.2015.05.050.
• Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient samplePanaich SS, Badheka AO, Arora S, Patel NJ, Thakkar B, Patel N, Singh V, Chothani A, Deshmukh A, Agnihotri K, Jhamnani S, Lahewala S, Manvar S, Panchal V, Patel A, Patel N, Bhatt P, Savani C, Patel J, Savani GT, Solanki S, Patel S, Kaki A, Mohamad T, Elder M, Kondur A, Cleman M, Forrest JK, Schreiber T, Grines C. Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample. Catheterization And Cardiovascular Interventions 2015, 87: 23-33. PMID: 26032938, DOI: 10.1002/ccd.25977.
• Comparison of Inhospital Outcomes and Hospitalization Costs of Peripheral Angioplasty and Endovascular StentingPanaich SS, Arora S, Patel N, Patel NJ, Lahewala S, Solanki S, Manvar S, Savani C, Jhamnani S, Singh V, Patel SV, Thakkar B, Patel A, Deshmukh A, Chothani A, Bhatt P, Savani GT, Patel J, Mavani K, Bhimani R, Tripathi B, Mohamad T, Remetz MS, Curtis JP, Attaran RR, Grines C, Mena CI, Cleman M, Forrest JK, Badheka AO. Comparison of Inhospital Outcomes and Hospitalization Costs of Peripheral Angioplasty and Endovascular Stenting. The American Journal Of Cardiology 2015, 116: 634-641. PMID: 26096999, DOI: 10.1016/j.amjcard.2015.05.031.
• Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve ImplantationBadheka AO, Patel NJ, Panaich SS, Patel SV, Jhamnani S, Singh V, Pant S, Patel N, Patel N, Arora S, Thakkar B, Manvar S, Dhoble A, Patel A, Savani C, Patel J, Chothani A, Savani GT, Deshmukh A, Grines CL, Curtis J, Mangi AA, Cleman M, Forrest JK. Effect of Hospital Volume on Outcomes of Transcatheter Aortic Valve Implantation. The American Journal Of Cardiology 2015, 116: 587-594. PMID: 26092276, DOI: 10.1016/j.amjcard.2015.05.019.
• A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trialLansky AJ, Schofer J, Tchetche D, Stella P, Pietras CG, Parise H, Abrams K, Forrest JK, Cleman M, Reinöhl J, Cuisset T, Blackman D, Bolotin G, Spitzer S, Kappert U, Gilard M, Modine T, Hildick-Smith D, Haude M, Margolis P, Brickman AM, Voros S, Baumbach A. A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: results from the DEFLECT III trial. European Heart Journal 2015, 36: 2070-2078. PMID: 25990342, DOI: 10.1093/eurheartj/ehv191.
• Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study.Baumbach A, Mullen M, Brickman AM, Aggarwal SK, Pietras CG, Forrest JK, Hildick-Smith D, Meller SM, Gambone L, den Heijer P, Margolis P, Voros S, Lansky AJ. Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: results from the DEFLECT I study. EuroIntervention 2015, 11: 75-84. PMID: 25868876, DOI: 10.4244/eijy15m04_01.
• Trends of Hospitalizations in the United States from 2000 to 2012 of Patients >60 Years With Aortic Valve DiseaseBadheka AO, Singh V, Patel NJ, Arora S, Patel N, Thakkar B, Jhamnani S, Pant S, Chothani A, Macon C, Panaich SS, Patel J, Manvar S, Savani C, Bhatt P, Panchal V, Patel N, Patel A, Patel D, Lahewala S, Deshmukh A, Mohamad T, Mangi AA, Cleman M, Forrest JK. Trends of Hospitalizations in the United States from 2000 to 2012 of Patients >60 Years With Aortic Valve Disease. The American Journal Of Cardiology 2015, 116: 132-141. PMID: 25983278, DOI: 10.1016/j.amjcard.2015.03.053.
• A balloon-expandable sheath facilitates transfemoral TAVR in patients with peripheral vascular disease and tortuosityGoldsweig AM, Faheem O, Cleman MW, Forrest JK. A balloon-expandable sheath facilitates transfemoral TAVR in patients with peripheral vascular disease and tortuosity. Therapeutic Advances In Cardiovascular Disease 2015, 9: 95-102. PMID: 25784499, DOI: 10.1177/1753944715575970.
• AORTIC VALVE DISEASE IN ELDERLY: TRENDS OF HOSPITALIZATIONS IN US, 2000-2012Badheka A, Singh V, Patel N, Arora S, Patel N, Thakkar B, Jhamnani S, Chothani A, Panaich S, Patel J, Deshmukh A, Manvar S, Mangi A, Pfau S, Cleman M, Forrest J. AORTIC VALVE DISEASE IN ELDERLY: TRENDS OF HOSPITALIZATIONS IN US, 2000-2012. Journal Of The American College Of Cardiology 2015, 65: a1951. DOI: 10.1016/s0735-1097(15)61951-9.
• Comparison of Inhospital Mortality, Length of Hospitalization, Costs, and Vascular Complications of Percutaneous Coronary Interventions Guided by Ultrasound Versus AngiographySingh V, Badheka AO, Arora S, Panaich SS, Patel NJ, Patel N, Pant S, Thakkar B, Chothani A, Deshmukh A, Manvar S, Lahewala S, Patel J, Patel S, Jhamnani S, Bhinder J, Patel P, Savani GT, Patel A, Mohamad T, Gidwani UK, Brown M, Forrest JK, Cleman M, Schreiber T, Grines C. Comparison of Inhospital Mortality, Length of Hospitalization, Costs, and Vascular Complications of Percutaneous Coronary Interventions Guided by Ultrasound Versus Angiography. The American Journal Of Cardiology 2015, 115: 1357-1366. PMID: 25824542, DOI: 10.1016/j.amjcard.2015.02.037.
• Multi‐Drug–Resistant Hypertension Caused by Severe Aortic Coarctation Presenting in Late AdulthoodMeller SM, Fahey JT, Setaro JF, Forrest JK. Multi‐Drug–Resistant Hypertension Caused by Severe Aortic Coarctation Presenting in Late Adulthood. Journal Of Clinical Hypertension 2015, 17: 313-316. PMID: 25644790, PMCID: PMC8032136, DOI: 10.1111/jch.12495.
• Transcatheter aortic valve replacementForrest JK, Mangi A, Vaitkeviciute I. Transcatheter aortic valve replacement. Current Opinion In Anaesthesiology 2015, 28: 107-112. PMID: 25486491, DOI: 10.1097/aco.0000000000000142.
• Comparison of Outcomes of Balloon Aortic Valvuloplasty Plus Percutaneous Coronary Intervention Versus Percutaneous Aortic Balloon Valvuloplasty Alone During the Same Hospitalization in the United StatesSingh V, Patel NJ, Badheka AO, Arora S, Patel N, Macon C, Savani GT, Manvar S, Patel J, Thakkar B, Panchal V, Solanki S, Patel N, Chothani A, Panaich SS, Ram V, Kliger CA, Schreiber T, Neill W, Cohen MG, Alfonso CE, Grines CL, Mangi A, Pfau S, Forrest JK, Cleman M, Makkar R. Comparison of Outcomes of Balloon Aortic Valvuloplasty Plus Percutaneous Coronary Intervention Versus Percutaneous Aortic Balloon Valvuloplasty Alone During the Same Hospitalization in the United States. The American Journal Of Cardiology 2014, 115: 480-486. PMID: 25543235, DOI: 10.1016/j.amjcard.2014.11.032.
• TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the USSingh V, Patel N, Badheka A, Patel N, Macon C, Savani G, Patel J, Thakkar B, Manvar S, Panchal V, Solanki S, Patel N, Chothani A, Kliger C, Schreiber T, O'Neill W, Cohen M, Alfonso C, Grines C, Forrest J, Cleman M, Makkar R. TCT-786 In-Hospital Outcomes of balloon aortic valvuloplasty and percutaneous coronary intervention during the same hospitalization in the US. Journal Of The American College Of Cardiology 2014, 64: b230. DOI: 10.1016/j.jacc.2014.07.859.
• PW083 Long term outcomes after percutaneous mitral commissurotomy in the real worldUribe C, Tenorio C, Eusse C, Rubio C, Ochoa J, Njoh R, Lombo B, Forrest J. PW083 Long term outcomes after percutaneous mitral commissurotomy in the real world. Global Heart 2014, 9: e277. DOI: 10.1016/j.gheart.2014.03.2222.
• Adjunctive Pharmacology for Coronary InterventionFaheem O, Forrest J. Adjunctive Pharmacology for Coronary Intervention. 2013, 143-156. DOI: 10.1007/978-1-4471-4528-8_11.
• Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT IV Trial at 2 YearsForrest JK, Lansky AJ, Meller SM, Hou L, Sood P, Applegate RJ, Wang JC, Skelding KA, Shah A, Kereiakes DJ, Sudhir K, Cristea E, Yaqub M, Stone GW. Evaluation of XIENCE V Everolimus-Eluting and Taxus Express2 Paclitaxel-Eluting Coronary Stents in Patients With Jailed Side Branches From the SPIRIT IV Trial at 2 Years. The American Journal Of Cardiology 2013, 111: 1580-1586. PMID: 23499270, DOI: 10.1016/j.amjcard.2013.01.330.
• Transcatheter aortic valve replacement: design, clinical application, and future challenges.Forrest JK. Transcatheter aortic valve replacement: design, clinical application, and future challenges. The Yale Journal Of Biology And Medicine 2012, 85: 239-47. PMID: 22737052, PMCID: PMC3375667.
• Aggregation of misfolded proteins can be a selective process dependent upon peptide composition.Milewski MI, Mickle JE, Forrest JK, Stanton BA, Cutting GR. Aggregation of misfolded proteins can be a selective process dependent upon peptide composition. The Journal Of Biological Chemistry 2002, 277: 34462-70. PMID: 12084728, DOI: 10.1074/jbc.M205420200.
• A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane.Milewski MI, Mickle JE, Forrest JK, Stafford DM, Moyer BD, Cheng J, Guggino WB, Stanton BA, Cutting GR. A PDZ-binding motif is essential but not sufficient to localize the C terminus of CFTR to the apical membrane. Journal Of Cell Science 2001, 114: 719-26. PMID: 11171377, DOI: 10.1242/jcs.114.4.719.